The National Anti-Profiteering Authority (NAA) has begun processing a slew of complaints against pharmacies, drug retailers and hospitals for failing to pass on goods and services tax (GST) cuts on life saving drugs and equipment to consumers during the covid-19 pandemic.
The move comes a year after some of them were reported to have fleeced consumers in the middle of India’s devastating second wave of the covid-19 pandemic.
In view of the pandemic, the GST Council last June cut GST rates on 18 Covid-19 related items including oxygen concentrators, Remdesivir and ambulance service.
The move holds considerable significance for consumers as this is the first time such complaints are being heard under an institutional mechanism. “We are receiving many complaints of profiteering by intermediaries on Covid-19 related items like oxygen concentrators and the drugs like Remdesivir as the GST Council last year slashed rates to benefit end users, who were already suffering from high medical cost due to the pandemic.